Profund Advisors LLC Eli Lilly & CO Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Profund Advisors LLC holds 12,498 shares of LLY stock, worth $9.95 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

12,498

Previous 13,438 7.0%

Holding current value

$9.95 Million

Previous $12.2 Million 8.99%

% of portfolio

0.43%

Previous 0.46%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $725,811 - $902,418	-940 Reduced 7.0%	12,498 $11.1 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $235,582 - $295,438	-325 Reduced 2.36%	13,438 $12.2 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $450,072 - $602,132	760 Added 5.84%	13,763 $10.7 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $192,219 - $226,601	-366 Reduced 2.74%	13,003 $7.58 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $234,738 - $323,622	-540 Reduced 3.88%	13,369 $7.18 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $68,394 - $91,451	-195 Reduced 1.38%	13,909 $6.52 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $2.05 Million - $2.4 Million	-6,589 Reduced 31.84%	14,104 $4.84 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $1.87 Million - $2.18 Million	5,812 Added 39.06%	20,693 $7.57 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $284,620 - $324,355	-960 Reduced 6.06%	14,881 $4.81 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $680,101 - $798,538	-2,440 Reduced 13.35%	15,841 $5.14 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $846,761 - $1.05 Million	-3,608 Reduced 16.48%	18,281 $5.24 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $508,610 - $631,188	2,262 Added 11.52%	21,889 $6.05 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $48,087 - $59,178	-217 Reduced 1.09%	19,627 $4.54 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $18,957 - $24,521	105 Added 0.53%	19,844 $4.55 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $538,148 - $696,658	-3,275 Reduced 14.23%	19,739 $3.69 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $26,222 - $34,698	201 Added 0.88%	23,014 $3.89 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $843,543 - $975,710	-5,769 Reduced 20.18%	22,813 $3.38 Million
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $913,877 - $1.1 Million	6,699 Added 30.61%	28,582 $4.69 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $962,995 - $1.19 Million	-8,089 Reduced 26.99%	21,883 $3.04 Million
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $246,022 - $304,721	2,301 Added 8.32%	29,972 $3.94 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $449,372 - $488,801	-4,208 Reduced 13.2%	27,671 $3.09 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $636,820 - $743,331	-5,748 Reduced 15.28%	31,879 $3.53 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $734,534 - $864,600	-6,599 Reduced 14.92%	37,627 $4.88 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.19 Million - $1.33 Million	-11,194 Reduced 20.2%	44,226 $5.12 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $1.12 Million - $1.4 Million	13,020 Added 30.71%	55,420 $5.95 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $309,083 - $354,731	-4,083 Reduced 8.78%	42,400 $3.62 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $198,140 - $233,891	-2,670 Reduced 5.43%	46,483 $3.6 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $1.06 Million - $1.13 Million	-12,894 Reduced 20.78%	49,153 $4.15 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $160,613 - $178,265	2,084 Added 3.48%	62,047 $5.31 Million
Q2 2017 Aug 11, 2017	BUY	N/A	59,963	59,963 $4.94 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Eli Lilly & CO Transaction History